RecruitingNot ApplicableNCT04938986

Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.


Sponsor

Hospital St. Joseph, Marseille, France

Enrollment

100 participants

Start Date

Apr 4, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluate the patient care recommandation induced by the IMMUNOSCORE® result


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a special tumor analysis tool called Immunoscore — which measures how well the immune system is fighting the cancer — can help predict which non-metastatic colorectal cancer patients are most likely to have their cancer return after surgery. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with colon cancer (adenocarcinoma type) confirmed by pathology - You have had curative surgery to remove your colon cancer (stage I, II, or III) - You are eligible to receive adjuvant (post-surgery) chemotherapy **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have had another solid tumor cancer within the last 3 years (except certain early-stage skin or cervical cancers) - You have conditions that prevent you from consenting or completing the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTIMMUNOSCORE®

recommendation for patient care according to the result of the IMMUNOSCORE®


Locations(2)

Hôpital Européen

Marseille, France

Hopital Saint Joseph

Marseille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04938986


Related Trials